Sanofi (BIT:1SAN)

Italy flag Italy · Delayed Price · Currency is EUR
84.64
+0.70 (0.83%)
At close: Dec 4, 2025
-9.96%
Market Cap 103.43B
Revenue (ttm) 45.93B
Net Income (ttm) 9.11B
Shares Out n/a
EPS (ttm) 7.39
PE Ratio 11.35
Forward PE 10.36
Dividend 3.92 (4.62%)
Ex-Dividend Date May 12, 2025
Volume 2,121
Average Volume 1,517
Open 83.12
Previous Close 83.94
Day's Range 83.10 - 85.14
52-Week Range 76.42 - 111.00
Beta 0.37
RSI 43.74
Earnings Date Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati... [Read more]

Sector Healthcare
Founded 1994
Employees 82,878
Stock Exchange Borsa Italiana
Ticker Symbol 1SAN
Full Company Profile

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial Statements

News

There is no news available yet.